Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • OncoSil Medical strengthens board with appointment of governance expert
    OncoSil Medical strengthens board with appointment of governance expert
    • News

  • Trading the ASX – Get your head around economic data releases
    Trading the ASX – Get your head around economic data releases
    • News

  • Cost cutting is all the rage right now
    Cost cutting is all the rage right now
    • News

  • HighCom delivers $11.4 million in new ballistics contracts following rocky leadership change
    HighCom delivers $11.4 million in new ballistics contracts following rocky leadership change
    • News

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

    AML3D announces stronger FY26, with positive EBITDA reported in the second half

    Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales pipeline as its bet on American defence manufacturing starts to pay off. AML3D Limited (ASX:AL3) has released 2026 financial year (FY26) results that included record revenue and order book levels, a positive EBITDA in the second half of the year,

    Read More
    Public
  • Refurbished tech gives Harris Technology a second life
    • News

    Refurbished tech gives Harris Technology a second life

    Harris Technology has found a higher-margin growth engine in an unlikely place: the market for second-hand laptops, computers and other electronic equipment, as cost-conscious Australians increasingly trade new-for-new for value. Harris Technology Group (ASX: HT8) has delivered what management describes as an inflection point, with a sharp rise in refurbished technology sales helping the online

    Read More
    Public
  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

    Imagion Biosystems Advances MagSense® Phase 2 Trial

    Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial towards patient enrolment, with key study partners now engaged and the investigational product ready for distribution. This impending trial takes the company a step closer to developing a more precise cancer imaging offering that fills a key gap in clinical

    Read More
    Public
  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

    Acrux-developed Menopause Hormone Therapy to enter Australian market

    Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market after expanding its licensing agreement with long-term partner Gedeon Richter Plc. The move could deliver Acrux up to AUD 5.4 million in milestone payments over a set period. The amended agreement comes at a critical time for Australian women, with

    Read More
    Public
  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

    Evion Expands Critical Minerals Push with Nevada Fluorspar Option

    The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry look to reduce dependence on imported materials used across batteries, semiconductors, defence and advanced manufacturing. Against that backdrop, Evion Group NL (ASX:EVG) has moved to establish exposure to another strategic mineral, announcing an option agreement over the historically producing CARP

    Read More
    Public
  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

    Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon cement replacement product Eco-Clay, signing a non-binding Memorandum of Understanding (MOU) with Holcim (Australia) Pty Ltd for supply into Holcim’s Victorian concrete operations. The agreement marks the first named commercial customer for Eco-Clay and comes just weeks after Green360 completed

    Read More
    Public
  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction

    Australia’s growing reliance on geospatial data across industries, from solar and property to environmental management, is driving demand for scalable aerial intelligence platforms. As more businesses embed location-based data into everyday workflows, distribution models that integrate directly into industry platforms are emerging as a key pathway to growth. Against this backdrop, Aerometrex Limited (ASX: AMX)

    Read More
    Public
  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks

    Companies’ efforts to grow their businesses can be compromised when factors outside their control start to adversely impact their financial performance. Market conditions at a sector- or even broader macro-level can seriously erode earnings potential – and with it, share price performance. Oftentimes these adverse effects are fleeting, and more normal trading conditions quickly return.

    Read More
    Public
  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project

    European Lithium (ASX: EUR) has confirmed that Critical Metals Corp. (NASDAQ: CRML) has secured 92.5% ownership of the Tanbreez Rare Earth Project in Greenland, following government approval to acquire the remaining 50.5% interest. The milestone, which will see European Lithium retain a minority stake in the latter project, gives Critical Metals Corp majority control over

    Read More
    Public
  • Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

    Harris Technology’s refurbished boom signals FY26 profit inflection

    Harris Technology Group (ASX: HT8) is on the cusp of a return to profitability, with surging demand for refurbished technology driving a material turnaround in its financial performance through FY26. In its March quarter update, the Company reported $4.6 million in revenue, underpinned by consistent momentum in its refurbished division, where monthly sales exceeded $0.7

    Read More
    Public
  • 1
  • 2
  • 3
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.